Pharmaceutical compositions
AssigneeJoyderma AG
InventorTeo Albarano
Life of this patent
Estimating the term…
Abstract
A composition including a synergistic combination of a vitamin D3 or a derivative or precursor thereof and hyaluronic acid or derivate thereof encapsulated in a lipid based colloidal carrier system (preferably lipid based vesicles such as liposomes, niosomes, tranferosomes) and topical formulations thereof, as well as their use in the prevention and/or treatment of inflamed skin and mucous membrane, especially in the prevention and/or treatment of skin photodamage, in particular in the prevention and/or treatment of skin erythema (skin inflammation) and actinic keratosis, as well non melanoma skin cancer.
Claims20
A method for preparing a homogeneous, stable liposomal hydrogel comprising the steps of:
- a) dispersing dried phospholipids at room temperature in a first aqueous solution to obtain phospholipid colloids;
- b) dispersing separately hyaluronic acid at room temperature in a second aqueous solution, wherein the hyaluronic acid is a mixture of low molecular, medium molecular, and high molecular weight hyaluronic acid;
- c) liquifying 7-dehydrocholesterol (7-DHC) at a temperature between 14° and 150° C.;
- d) adding an organic solvent to the liquified 7-DHC obtained in step c) to obtain a mixture;
- e) admixing the mixture obtained in step d) to the phospholipid colloids obtained in step a) under stirring at room temperature to obtain colloidal spheres of 20-150 nm;
- f) adding the dispersed hyaluronic acid obtained in step b) to the colloidal spheres of step e) to obtain a further mixture;
- and
- g) continue stirring the further mixture at room temperature to obtain a homogeneous, stable liposomal hydrogel comprising the 7-DHC and the mixture of hyaluronic acids encapsulated in phospholipid colloids.
Dependencies are inferred from the claim text.